{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:27:37Z","timestamp":1785799657953,"version":"3.56.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T00:00:00Z","timestamp":1516320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H26-nanchitou (nan)-ippan-036"],"award-info":[{"award-number":["H26-nanchitou (nan)-ippan-036"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s10157-018-1531-0","type":"journal-article","created":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T07:14:15Z","timestamp":1516346055000},"page":"924-930","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clinical features in a series of 258 Japanese pediatric patients with thrombotic microangiopathy"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5972-946X","authenticated-orcid":false,"given":"Akira","family":"Ashida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Sawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Fujimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Shirasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyogo","family":"Nakakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumoto","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,19]]},"reference":[{"key":"1531_CR1","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s10157-016-1276-6","volume":"20","author":"H Kato","year":"2016","unstructured":"Kato H, Nangaku M, Hataya H, Sawai T, Ashida A, Fujimaru R, Hidaka Y, Kaname S, Maruyama S, Yasuda T, Yoshida Y, Ito S, Hattori M, Miyakawa Y, Fujimura Y, Okada H, Kagami S, The Joint Committee for the Revision of Clinical Guides of Atypical Hemolytic Uremic Syndrome in Japan. Clinical guides for atypical hemolytic uremic syndrome in Japan. Clin Exp Nephrol. 2016;20:536\u201343. \n                    https:\/\/doi.org\/10.1007\/s10157-016-1276-6\n                    \n                  .","journal-title":"Clin Exp Nephrol"},{"key":"1531_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30062-4","author":"F Fakhouri","year":"2017","unstructured":"Fakhouri F, Zuber J, Fr\u00e9meaux-Bacchi V, Loirat C. Haemolytic uraemic syndrome. Lancet. 2017. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(17)30062-4\n                    \n                   (Epub ahead of Print).","journal-title":"Lancet."},{"key":"1531_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00431-015-2642-1","volume":"175","author":"G Ardissino","year":"2016","unstructured":"Ardissino G, Salardi S, Colombo E, Testa S, Borsa-Ghiringhelli N, Paglialonga F, Paracchini V, Tel F, Possenti I, Belingheri M, Civitillo CF, Sardini S, Ceruti R, Baldioli C, Tommasi P, Parola F, Tedeschi S. Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network. Eur J Pediatr. 2016;175:465\u201373. \n                    https:\/\/doi.org\/10.1007\/s00431-015-2642-1\n                    \n                  .","journal-title":"Eur J Pediatr"},{"key":"1531_CR4","unstructured":"National Institute of Infection Diseases and Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare. Infectious agents surveillance report. 2016;37:85\u2013102. \n                    http:\/\/www.nih.go.jp\/niid\/ja\/iasr.html\n                    \n                  . Accessed 7 June 2017"},{"key":"1531_CR5","unstructured":"National Institute of Infection Diseases and Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare. Infectious agents surveillance report. 2015;36:73\u201392. \n                    http:\/\/www.nih.go.jp\/niid\/ja\/iasr.html\n                    \n                  . Accessed 7 June 2017"},{"key":"1531_CR6","unstructured":"National Institute of Infection Diseases and Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare. Infectious agents surveillance report. 2014;35:117\u201336. \n                    http:\/\/www.nih.go.jp\/niid\/ja\/iasr.html\n                    \n                  . Accessed 7 June 2017"},{"key":"1531_CR7","unstructured":"National Institute of Infection Diseases and Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare. Infectious agents surveillance report. 2013;34:123\u201354. \n                    http:\/\/www.nih.go.jp\/niid\/ja\/iasr.html\n                    \n                  . Accessed 7 June 2017"},{"key":"1531_CR8","doi-asserted-by":"publisher","first-page":"S424","DOI":"10.1093\/cid\/cis208","volume":"54","author":"KL Ong","year":"2012","unstructured":"Ong KL, Apostal M, Comstock N, Hurd S, Webb TH, Mickelson S, Scheftel J, Smith G, Shiferaw B, Boothe E, Gould LH. Strategies for surveillance of pediatric hemolytic uremic syndrome: Foodborne disease active surveillance network (FoodNet), 2000\u20132007. Clin Infect Dis. 2012;54:S424\u201331. \n                    https:\/\/doi.org\/10.1093\/cid\/cis208\n                    \n                  .","journal-title":"Clin Infect Dis"},{"key":"1531_CR9","unstructured":"OECD-FAO Agricultural outlook (2017) Meat consumption. \n                    https:\/\/data.oecd.org\/agroutput\/meat-consumption.htm\n                    \n                  . Accessed 7 June 2017"},{"key":"1531_CR10","unstructured":"Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report (MMWR). Incidence and trends of infection with pathogens transmitted commonly through food\u2014foodborne disease active surveillance network, 10 US sites, 2006\u20132013. \n                    https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6315a3.htm\n                    \n                  . Accessed 7 June 2017"},{"key":"1531_CR11","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.3201\/eid2212.160783","volume":"22","author":"T Morita-Ishihara","year":"2016","unstructured":"Morita-Ishihara T, Iyoda S, Iguchi A, Ohnishi M. Emerg Infect Dis. 2016;22:2181\u20134. \n                    https:\/\/doi.org\/10.3201\/eid2212.160783\n                    \n                  .","journal-title":"Emerg Infect Dis"},{"key":"1531_CR12","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00467-008-0935-6","volume":"23","author":"J Scheiring","year":"2008","unstructured":"Scheiring J, Andreoli SP, Zimmerhackl LB. Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol. 2008;23:1749\u201360. \n                    https:\/\/doi.org\/10.1007\/s00467-008-0935-6\n                    \n                  .","journal-title":"Pediatr Nephrol"},{"key":"1531_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1086\/341940","volume":"186","author":"A Gerber","year":"2002","unstructured":"Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997\u20132000, in Germany and Austria: a prospective Study. J Infect Dis. 2002;186:493\u2013500. \n                    https:\/\/doi.org\/10.1086\/341940\n                    \n                  .","journal-title":"J Infect Dis"},{"key":"1531_CR14","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1007\/s00467-012-2383-6","volume":"28","author":"JM Spinale","year":"2013","unstructured":"Spinale JM, Ruebner RL, Copelovitch L, Kaplan BS. Long-term outcomes of Shiga toxin hemolytic uremic syndrome. Pediatr Nephrol. 2013;28:2097\u2013105. \n                    https:\/\/doi.org\/10.1007\/s00467-012-2383-6\n                    \n                  .","journal-title":"Pediatr Nephrol"},{"key":"1531_CR15","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/cid\/cis196","volume":"54","author":"A Rosales","year":"2012","unstructured":"Rosales A, Hofer J, Zimmerhackl LB, Jungraithmayr TC, Riedl M, Giner T, Strasak A, Orth-H\u00f6ller D, W\u00fczner R, Karch H, For the German\u2013Austrian HUS Study Group. Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis. 2012;54:1413\u201321. \n                    https:\/\/doi.org\/10.1093\/cid\/cis196\n                    \n                  .","journal-title":"Clin Infect Dis."},{"key":"1531_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/archdischild-2015-309471","volume":"101","author":"AM Durkan","year":"2016","unstructured":"Durkan AM, Kim S, Craig J, Elliot E. The long-term outcomes of atypical haemolytic uraemic syndrome: a national surveillance study. Arch Dis Child. 2016;101:387\u201391. \n                    https:\/\/doi.org\/10.1136\/archdischild-2015-309471\n                    \n                  .","journal-title":"Arch Dis Child"},{"key":"1531_CR17","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/CJN.02210310","volume":"5","author":"M Noris","year":"2010","unstructured":"Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol. 2010;5:1844\u201359. \n                    https:\/\/doi.org\/10.2215\/CJN.02210310\n                    \n                  .","journal-title":"Clin J Am Soc Nephrol"},{"key":"1531_CR18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2215\/CJN.04760512","volume":"8","author":"V Fremeaux-Bacchi","year":"2013","unstructured":"Fremeaux-Bacchi V, Fakhouri F, Gamier A, Biena\u00edm\u00e9 F, Dragon-Durey MA, Ngo S, Moulin B, Servais A, Provot F, Rostaing L, Burtey S, Niaudet P, Desch\u00eanes G, Lebranchu Y, Zuber J, Loirat C. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol. 2013;8:554\u201362. \n                    https:\/\/doi.org\/10.2215\/CJN.04760512\n                    \n                  .","journal-title":"Clin J Am Soc Nephrol"},{"key":"1531_CR19","doi-asserted-by":"publisher","first-page":"E1445","DOI":"10.1002\/humu.21256","volume":"31","author":"TK Maga","year":"2010","unstructured":"Maga TK, Nishimura CJ, Weaver AE, Frees KL, Smith RJH. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum Mutat Brief. 2010;31:E1445\u201360. \n                    https:\/\/doi.org\/10.1002\/humu.21256\n                    \n                  .","journal-title":"Hum Mutat Brief"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-018-1531-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1531-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1531-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T20:01:18Z","timestamp":1547841678000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-018-1531-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,19]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1531"],"URL":"https:\/\/doi.org\/10.1007\/s10157-018-1531-0","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,19]]},"assertion":[{"value":"10 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Kazumoto Iijima had endowed department by Astellas Pharma, and has received grants from Daiichi Sankyo Co., Ltd., Toshihiro Sawai received travel fees from Alexion Pharma. The other authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The survey was conducted in accordance with the ethical principles contained within the 1964 Declaration of Helsinki, and the ethical guidelines for epidemiological studies issued by the Ministry of Health, Labour and Welfare, Japan. The survey was approved by the ethics board of Osaka Medical College (approval number: 1823) before the study commenced.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"For this type of study, formal consent was not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}